Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,016Revenue $M313Net Margin (%)5.5Z-Score3.2
Enterprise Value $M1,025EPS $0.9Operating Margin %9.2F-Score5
P/E(ttm))56.8Cash Flow Per Share $0.9Pre-tax Margin (%)8.1Higher ROA y-yN
Price/Book2.010-y EBITDA Growth Rate %3.4Quick Ratio3.9Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %-4.3Current Ratio4.7Lower Leverage y-yN
Price/Cash Flow17.0y-y EBITDA Growth Rate %-2.4ROA % (ttm)2.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)4.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M37.6ROI % (ttm)5.1Gross Margin Increase y-yN

Gurus Latest Trades with EBS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EBSJoel Greenblatt 2014-09-30 Sold Out -0.06%$21.31 - $24.9
($22.93)
$ 27.0518%Sold Out0
EBSJohn Burbank 2014-06-30 Sold Out -0.01%$20.42 - $26.78
($23.3)
$ 27.0516%Sold Out0
EBSJoel Greenblatt 2014-03-31 Buy 0.1%$22.85 - $28.09
($25.19)
$ 27.057%New holding, 258760 sh.258,760
EBSJohn Burbank 2014-03-31 Buy 0.01%$22.85 - $28.09
($25.19)
$ 27.057%New holding, 7987 sh.7,987
EBSJohn Rogers 2014-03-31 Sold Out -0.04%$22.85 - $28.09
($25.19)
$ 27.057%Sold Out0
EBSJohn Rogers 2013-12-31 Add0.02%$17.71 - $23.95
($20.84)
$ 27.0530%Add 105.79%122,650
EBSJohn Rogers 2013-09-30 Add0.01%$15.22 - $19.43
($17.88)
$ 27.0551%Add 116.73%59,600
EBSJohn Rogers 2013-06-30 Buy 0.01%$13.08 - $15.73
($14.48)
$ 27.0587%New holding, 27500 sh.27,500
EBSJoel Greenblatt 2013-03-31 Sold Out -0.14%$13.95 - $16.9
($15.67)
$ 27.0573%Sold Out0
EBSJoel Greenblatt 2012-12-31 Buy 0.14%$12.91 - $16.09
($14.64)
$ 27.0585%New holding, 147099 sh.147,099
EBSKen Fisher 2012-12-31 Add$12.91 - $16.09
($14.64)
$ 27.0585%Add 21.09%401,700
EBSJoel Greenblatt 2011-12-31 Sold Out -0.08%$15.43 - $19.64
($17.41)
$ 27.0555%Sold Out0
EBSKen Fisher 2011-06-30 Add0.01%$20.66 - $24.98
($23.2)
$ 27.0517%Add 160.57%300,305
EBSJoel Greenblatt 2011-06-30 Reduce-0.05%$20.66 - $24.98
($23.2)
$ 27.0517%Reduce -20.74%26,620
EBSJoel Greenblatt 2011-03-31 Add0.17%$20.64 - $24.55
($22.62)
$ 27.0520%Add 243.58%33,585
EBSKen Fisher 2011-03-31 Buy 0.01%$20.64 - $24.55
($22.62)
$ 27.0520%New holding, 115250 sh.115,250
EBSJoel Greenblatt 2010-12-31 Buy 0.07%$17.59 - $23.8
($19.23)
$ 27.0541%New holding, 9775 sh.9,775
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EBS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
EBS Ken Fisher 2014-09-30483,3281.290.02+3.11%
EBS Joel Greenblatt 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


EBS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Richard RonaldDirector 2014-12-17Sell5,000$270.19view
El-Hibri FuadChairman, 10% Owner 2014-12-11Sell119,341$264.04view
El-Hibri FuadChairman, 10% Owner 2014-11-28Sell34,577$258.2view
El-Hibri FuadChairman, 10% Owner 2014-11-25Sell9,014$258.2view
Harsanyi ZsoltDirector 2014-11-25Sell8,000$24.828.98view
El-Hibri FuadChairman, 10% Owner 2014-11-12Sell2,311$258.2view
Kramer RobertEVP & CFO 2014-11-07Sell2,625$2412.71view
El-Hibri FuadChairman, 10% Owner 2014-09-02Sell1,633$258.2view
El-Hibri FuadChairman, 10% Owner 2014-08-26Sell70,796$258.2view
Kramer RobertCFO 2014-04-16Sell50,189$24.3411.13view

Press Releases about EBS :

    Quarterly/Annual Reports about EBS:

    News about EBS:

    Articles On GuruFocus.com
    Emergent BioSolutions Inc. Reports Operating Results (10-Q) Nov 05 2010 
    Emergent BioSolutions Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Emergent BioSolutions Inc. (EBS) President & COO Daniel Abdun-nabi sells 18,150 Shares Jul 30 2010 
    Weekly CEO Sells Highlight: Yum! Brands Inc, Marchex Inc, iGate Corp, and Emergent BioSolutions Inc. Jul 25 2010 
    Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 18,800 Shares Jul 23 2010 
    Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 130,100 Shares Jul 22 2010 
    Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 84,433 Shares Jul 19 2010 
    Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 52,000 Shares May 14 2010 
    Emergent BioSolutions Inc. Reports Operating Results (10-Q) May 06 2010 
    Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 25,000 Shares Apr 29 2010 

    More From Our Partners
    Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog Dec 18 2014 - ZACKS

    More From Other Websites
    Emergent BioSolutions Expands Biodefense Franchise; Acquires Portfolio of Broad Spectrum Antibiotics Dec 17 2014
    Emergent BioSolutions Expands Biodefense Franchise; Acquires Portfolio of Broad Spectrum Antibiotics Dec 17 2014
    2:37 am Emergent BioSolutions acquires EV-035 Series from Evolva Dec 17 2014
    Evolva sells EV-035 Series to Emergent BioSolutions Dec 17 2014
    Evolva Sells EV-035 Series to Emergent BioSolutions Dec 17 2014
    12.12.2014 - Petr Brávek new Chief Operations Officer of Erste Group Dec 12 2014
    09.12.2014 - Erste Group announces that no coupons will be paid on supplementary (upper tier 2)... Dec 09 2014
    04.12.2014 - 2015 Outlook for Stock Markets and the Vienna Stock Exchange Dec 04 2014
    01.12.2014 - Erste Bank Savings and Credit Forecast Q3 Dec 01 2014
    20.11.2014 - Erste Group and Erste Bank Croatia to finance new wind farm in Croatia Nov 27 2014
    Emergent BioSolutions to Webcast Presentation at 25th Annual Oppenheimer Healthcare Conference Nov 24 2014
    Emergent BioSolutions to Webcast Presentation at 25th Annual Oppenheimer Healthcare Conference Nov 24 2014
    EMERGENT BIOSOLUTIONS INC. Financials Nov 19 2014
    14.11.2014 - Framework programme for Erste Group share transactions by savings banks of the... Nov 14 2014
    10-Q for Emergent BioSolutions, Inc. Nov 12 2014
    11.11.2014 - 25 years after communism - can CEE climb its way back to growth? Nov 11 2014
    30.10.2014 - Erste Group: asset quality improvement gains momentum as AQR confirms solid capital... Nov 11 2014
    11.11.2014 - 25 years after communism - can CEE climb its way back to growth? Nov 11 2014
    EMERGENT BIOSOLUTIONS INC. Files SEC form 10-Q, Quarterly Report Nov 10 2014
    Emergent BioSolutions Beats on Q3 Earnings, Guidance Up Nov 10 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK